Institutes
August 24, 2021
UAMS Winthrop P. Rockefeller Cancer Institute ‘Be a Part of the Cure’ Telethon Airs Statewide on ABC Sept. 8
Arkansans are invited to “Be a Part of the Cure” on Sept. 8 when the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) holds its second televised event to raise funds and awareness for its cancer research and treatment programs. The event is set for 11 a.m. – 6:30…
August 23, 2021
UAMS Researchers Awarded $2.5 Million Grant to Create Phone App to Prevent Opioid Use Relapse
LITTLE ROCK — A team of UAMS research scientists has been awarded a five-year grant worth $2.5 million from the National Institute on Drug Abuse to determine if a cell phone application can reduce the relapse rate in people with opioid use disorder.
August 19, 2021
UAMS Researcher Leading $3.1 Million Preschool Intervention to Reduce Obesity and Cancer in Arkansas, Louisiana
UAMS is leading a major new effort to reduce cancer by addressing eating habits in early childcare and education settings. The project, led by UAMS’ Taren Swindle, Ph.D., will reach about 5,000 children and 500 teachers across Arkansas and Louisiana.
August 10, 2021
UAMS Research Sheds Light on Vaccine Hesitancy in Arkansas
Researchers at UAMS have found that trust in vaccines, fear of infection, and race or ethnicity play a large role in whether or not people will get a COVID-19 vaccine, particularly when looking at socio-demographic factors.
Samer Al Hadidi, M.D., Joins the UAMS Myeloma Center
LITTLE ROCK — Samer Al Hadidi, M.D., has joined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), where he will treat patients with myeloma and other plasma cell disorders. “I’m very happy to welcome Dr. Al Hadidi to our staff,” said Frits van Rhee,…
August 9, 2021
UAMS Offering Revolutionary CAR T-Cell Therapy for Myeloma Patients
The Myeloma Center at the UAMS Winthrop P. Rockefeller Cancer Institute is offering a new cutting-edge immunotherapy treatment for myeloma patients. The University of Arkansas for Medical Sciences (UAMS) is the first and only medical facility in Arkansas approved to provide cellular therapy to myeloma patients.
July 23, 2021
Grateful Patient Honors UAMS Opthalmologist with $162,000 Gift to Harvey & Bernice Jones Eye Institute
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has received a $162,000 commitment from Karen and Roy Burks in honor of John Shock, M.D., to support research at the Harvey & Bernice Jones Eye Institute. “Patient care from Dr. John Shock as well as other faculty at the Jones Eye Institute has…
July 22, 2021
UAMS Performs First GammaTile Brain Surgery in Arkansas
LITTLE ROCK — Radiation oncologist Richard Crownover, M.D., Ph.D., and neurosurgeon Analiz Rodriguez, M.D., Ph.D., and their care team at the University of Arkansas for Medical Sciences (UAMS) have performed the state’s first application of GammaTile Therapy.
July 21, 2021
Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team
LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…
July 20, 2021
UAMS Releases Findings from Statewide COVID-19 Antibody Study
LITTLE ROCK — A statewide COVID-19 antibody study led by UAMS found that by the end of 2020, 7.4% of Arkansans had antibodies to the virus, but there were wide disparities among racial and ethnic groups. UAMS researchers released their findings this week to a public database, medRxiv (med archive).
Previous page Next page